Journals
Consult the user guide
For assistance, please contact us
Consult the user guide
For assistance, please contact us
Add search criteria
Results: 1 - 15 of 82
2021-06-16 [p.1122]
Q-686 — Mrs. McLeod (Kamloops—Thompson—Cariboo) — With regard to the government’s requirements for hotels being used as quarantine facilities: (a) what specific obligations do the hotels have with regard to security standards; (b) what specific measures has the government taken to ensure these security standards are being met; (c) how many instances have occurred where government inspectors have found that the security standards of these hotels were not being met; (d) of the instances in (c), how many times did the security failures jeopardize the safety of (i) the individuals staying in the facility, (ii) public health or the general public; (e) are hotels required to verify that someone has received a negative test prior to leaving the facility, and, if so, how is this specifically being done; and (f) how many individuals have left these facilities without receiving a negative test result? — Sessional Paper No. 8555-432-686.
2021-06-16 [p.1123]
Q-687 — Mrs. McLeod (Kamloops—Thompson—Cariboo) — With regard to the government’s requirements for hotels to become a government-authorized hotel for the purpose of quarantining returning international air travellers: (a) what specific obligations do the hotels have with regard to security standards; (b) what specific measures has the government taken to ensure these security standards are being met; (c) how many instances have occurred where government inspectors have found that the security standards of these hotels were not being met; (d) of the instances in (c), how many times did the security failures jeopardize the safety of (i) the individuals staying in the facility, (ii) public health or the general public; (e) how many criminal acts have been reported since the hotel quarantine requirement began at each of the properties designated as a government-authorized hotel; (f) what is the breakdown of (e) by type of offence; (g) are the hotels required to verify that someone has received a negative test prior to leaving the facility, and, if so, how is this specifically being done; (h) how many individuals have left these hotels prior to or without receiving a negative test result; and (i) how does the government track whether or not individuals have left these hotels prior to receiving a negative test result? — Sessional Paper No. 8555-432-687.
2021-06-16 [p.1124]
Q-691 — Mr. Hoback (Prince Albert) — With regard to the deal reached between the government and Pfizer Inc. for COVID-19 vaccine doses through 2024: (a) what COVID-19 modelling was used to develop the procurement agreement; and (b) what specific delivery timetables were agreed to? — Sessional Paper No. 8555-432-691.
2021-06-16 [p.1124]
Q-692 — Mr. Hoback (Prince Albert) — With regard to the testimony of the CEO of BioPharma Services at the House of Commons' Standing Committee on International Trade on Friday, April 23, 2021, pertaining to potential future waves of COVID-19 and the need for trading blocs: (a) have the Minister of Finance and her department been directed to plan supports for Canadians affected by subsequent waves of the virus through 2026; (b) what is the current status of negotiations or discussions the government has entered into with our allies about the creation of trading blocs for vaccines and personal protective equipment; (c) which specific countries have been involved in discussions about potential trading blocs; and (d) what are the details of all meetings where negotiations or discussions that have occurred about potential trading, including the (i) date, (ii) participants, (iii) countries represented by participants, (iv) meeting agenda and summary? — Sessional Paper No. 8555-432-692.
2021-06-16 [p.1128]
Q-706 — Mr. Hallan (Calgary Forest Lawn) — With regard to COVID-19 specimen collection from travellers completed at Canada’s ports of entry and through at home specimen collection kits: (a) what company performs the tests of specimens collected from each port of entry; (b) what company performs the tests of at home specimen collection kits; (c) what city and laboratory are specimens collected from each port of entry, sent to for processing; (d) what city and laboratory are at home specimen collection kits processed; (e) what procurement process did the government undertake in selecting companies to collect and process COVID-19 specimens; (f) what companies submitted bids to collect and process COVID-19 specimens; (g) what are the details of the bids submitted by companies in (f); and (h) what are the details of the contracts entered into between the government and any companies that have been hired to collect and process COVID-19 specimens? — Sessional Paper No. 8555-432-706.
2021-06-16 [p.1129]
Q-711 — Mr. Shields (Bow River) — With regard to free rapid COVID-19 tests distributed by the government directly to companies for the screening of close-contact employees: (a) how many tests were distributed; (b) which companies received the tests; and (c) how many tests did each company in (b) receive? — Sessional Paper No. 8555-432-711.
2021-06-16 [p.1131]
Q-722 — Mr. Albas (Central Okanagan—Similkameen—Nicola) — With regard to COVID-19 vaccines and having to throw them away due to spoilage or expiration: (a) how much spoilage and waste has been identified; (b) what is the spoilage and waste breakdowns by province; and (c) what is the cost to taxpayers for the loss of spoiled vaccines? — Sessional Paper No. 8555-432-722.
2021-06-14 [p.1101]
Q-665 — Mr. Dreeshen (Red Deer—Mountain View) — With regard to exemptions from the quarantine rules for individuals entering Canada, broken down by month since March 1, 2020: (a) how many individuals have received exemptions from the quarantine requirements, broken down by reason for the exemption (essential worker, amateur sports, etc.); and (b) how many individuals received exemptions from the quarantine requirements after receiving a ministerial exemption, such as a national interest designation, broken down by minister and type of designation? — Sessional Paper No. 8555-432-665.
2021-06-14 [p.1101]
Q-666 — Ms. Rempel Garner (Calgary Nose Hill) — With regard to the government's use of Switch Health for post-arrival coronavirus tests for travellers: (a) what are the service standards in terms of distributing, picking up, and processing tests; (b) what are the service standards for responding to client inquiries or complaints; (c) in what percentage of cases did Switch Health meet or exceed service standards; (d) for cases where standards were not met, what was the reason given; (e) how many of the required post-arrival tests were never completed; (f) of the tests in (e), what is the breakdown by reason (Switch Health unable to provide service in Spanish, traveler refusal, etc.); (g) was there a competitive bid process for the contract awarded to Switch Health and, if so, who were the other bidders; and (h) what are the details of all meetings, including telephone or virtual, that Switch Health had with the government prior to the awarding of the contract, including the (i) date, (ii) names and titles of representatives from Switch Health, (iii) names and titles of government representatives, including any ministerial staff? — Sessional Paper No. 8555-432-666.
2021-06-14 [p.1104]
Q-678 — Ms. Bergen (Portage—Lisgar) — With regard to sole-sourced contracts related to COVID-19 spending since November 25, 2020: (a) how many contracts have been sole-sourced; (b) what are the details of each sole-sourced contract, including the (i) date of the award, (ii) description of goods or services, including volume, (iii) final amount, (iv) vendor, (v) country of vendor; (c) how many sole-sourced contracts have been awarded to domestic-based companies; and (d) how many sole-sourced contracts have been awarded to foreign-based companies, broken down by country where the company is based? — Sessional Paper No. 8555-432-678.
2021-06-11 [p.1085]
Q-649 — Mr. Baldinelli (Niagara Falls) — With regard to the government's decision to require airline travellers arriving from outside of Canada to quarantine at a designated airport hotel: (a) how many travellers refused to stay in a government approved quarantine hotel; (b) how many fines or tickets were issued by the Public Health Agency of Canada related to the refusals in (a); and (c) what is the breakdown of (a) and (b) by airport of entry? — Sessional Paper No. 8555-432-649.
2021-06-11 [p.1086]
Q-652 — Mr. Kent (Thornhill) — With regard to Canada Border Services Agency (CBSA) and individuals presenting COVID-19 test results at points of entry, since testing requirements were put into place in January 2021, broken down by type of crossing (land, air): (a) how many individuals did the CBSA intercept with a suspected fraudulent or false test result; (b) how many individuals did the CBSA intercept with a test result that was otherwise deemed unsatisfactory, such as the wrong type of test; (c) of the individuals in (a), how many were (i) admitted to Canada, (ii) denied entry; (d) of the individuals in (a), how many were (i) ticketed or fined by the CBSA, (ii) had their cases referred to the RCMP or other law enforcement agencies; and (e) of the cases in (b), how many were (i) admitted to Canada, (ii) denied entry? — Sessional Paper No. 8555-432-652.
2021-05-31 [p.1006]
Q-608 — Mr. Shipley (Barrie—Springwater—Oro-Medonte) — With regard to the Supplementary Estimates (A), (B) and (C), 2020-21 and the items listed under Privy Council Office as COVID-19 communications and marketing: (a) what was the total amount actually spent under this line item; (b) what is the detailed breakdown of how the money was spent, including a detailed breakdown by (i) type of expenditure, (ii) type of communications and marketing, (iii) specific message being communicated; (c) what are the details of all contracts signed under this line item, including the (i) vendor, (ii) amount, (iii) date, (iv) detailed description of goods or services, including the volume; and (d) was any funding under this line item transferred to another department or agency, and, if so, what is the detailed breakdown and contract details of how that money was spent? — Sessional Paper No. 8555-432-608.
2021-05-31 [p.1008]
Q-615 — Mr. Brassard (Barrie—Innisfil) — With regard to reports that some arriving air travelers are having their expenses for quarantining at a designated hotel or other quarantine facility covered by the government: (a) how many arriving travelers have had their quarantine expenses covered by the government since the hotel quarantine requirement began, broken down by airport point of entry; (b) what specific criteria is used by the government to determine which travelers are required to pay for their own hotel quarantine and which travelers have their quarantine paid for by the government; and (c) what are the estimated total expenditures by the government on expenses related to quarantining the travelers in (a), broken down by line item and type of expense? — Sessional Paper No. 8555-432-615.
2021-05-26 [p.979]
Q-592 — Mr. Kurek (Battle River—Crowfoot) — With regard to correctional facilities under the purview of the Correctional Service of Canada during the COVID-19 pandemic, since March 1, 2020, broken down by month, institution and the security level of the institution: (a) what was the number of confirmed cases of COVID-19 contracted by (i) inmates, (ii) staff; (b) how many (i) inmates, (ii) staff, have died from COVID-19; (c) how many (i) inmates, (ii) staff, have died from suicide; (d) what methods were used to count or determine the number of COVID-19 cases in institution; (e) which department or government agency is responsible for developing measures used to stop the spread of COVID-19 and its variants in correctional facilities; (f) what measures were instated to ensure personal protective equipment distribution to (i) guards, (ii) inmates, (iii) visitors; (g) since the pandemic began, what specific health guidelines have been put in place to stop the spread of COVID-19 by or to (i) guards, (ii) inmates, (iii) visitors, and on what date was each measure put into place; and (h) for each guideline in (g), which advisory body or regional health authority recommended the guideline? — Sessional Paper No. 8555-432-592.
Results: 1 - 15 of 82 | Page: 1 of 6

1
2
3
4
5
6
>
>|
Export As: XML CSV RSS

For more data options, please see Open Data